Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab versus mitomycin C in trabeculectomy for primary open-angle glaucoma
RBR-9wkw73jRecruiting
- Sponsor
- UNIME
- Start
- May 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in open-angle glaucoma (OAG) comparing Trabeculectomy + intravitreal Avastin with Trabeculectomy + mitomycin C (2 arms). Primary endpoints: Postoperative intraocular pressure and Reduction in intraocular pressure from baseline. Started May 2020; status: recruiting.
02
Drugs
bevacizumabmitomycin c
03
Conditions
open-angle glaucoma (OAG)
Beyond the preview
Go deeper on RBR-9wkw73j.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9wkw73j.